Axios @axios
After settling with the FTC, the pharmaceutical company once led by 'Pharma Bro' Martin Shkreli must pay victims of its 2015 move to raise the price of a life-saving drug by 4,000%. Shkreli, who didn't reach a settlement, is set to begin trial on Dec. 14. https://t.co/yIU3yZl5x0 — PolitiTweet.org